HC Wainwright Lifts Earnings Estimates for Core Scientific

Core Scientific, Inc. (NASDAQ:CORZ) – Equities research analysts at HC Wainwright increased their Q2 2025 earnings per share estimates for shares of Core Scientific in a note issued to investors on Thursday, May 8th. HC Wainwright analyst K. Dede now expects that the company will earn ($0.09) per share for the quarter, up from their prior estimate of ($0.10). HC Wainwright currently has a “Buy” rating and a $17.00 target price on the stock. The consensus estimate for Core Scientific’s current full-year earnings is $0.52 per share. HC Wainwright also issued estimates for Core Scientific’s Q3 2025 earnings at $0.02 EPS, Q4 2025 earnings at $0.02 EPS and FY2025 earnings at $0.25 EPS.

Core Scientific (NASDAQ:CORZ) last issued its earnings results on Wednesday, May 7th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.02. The business had revenue of $79.53 million for the quarter, compared to analysts’ expectations of $92.04 million. The business’s quarterly revenue was down 55.6% on a year-over-year basis. During the same period last year, the company posted $0.78 earnings per share.

A number of other equities analysts also recently issued reports on the company. Compass Point cut their target price on Core Scientific from $26.00 to $20.00 and set a “buy” rating for the company in a research note on Tuesday, February 25th. Needham & Company LLC cut their target price on Core Scientific from $18.00 to $17.00 and set a “buy” rating for the company in a research note on Thursday, February 27th. Craig Hallum began coverage on Core Scientific in a report on Tuesday, January 21st. They issued a “buy” rating and a $24.00 price target on the stock. Canaccord Genuity Group restated a “buy” rating and issued a $17.00 price target on shares of Core Scientific in a report on Friday. Finally, Keefe, Bruyette & Woods began coverage on Core Scientific in a report on Monday, January 27th. They issued an “outperform” rating and a $22.00 price target on the stock. Fifteen analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Core Scientific has an average rating of “Buy” and a consensus price target of $19.07.

Core Scientific Trading Up 6.0%

Shares of CORZ stock opened at $9.88 on Monday. The company has a market cap of $2.91 billion, a price-to-earnings ratio of -1.83 and a beta of 6.66. The stock has a 50 day simple moving average of $7.93 and a 200-day simple moving average of $12.04. Core Scientific has a 12-month low of $3.46 and a 12-month high of $18.63.

Insider Buying and Selling at Core Scientific

In related news, Director Jordan Levy bought 62,500 shares of the stock in a transaction on Thursday, March 6th. The shares were purchased at an average price of $8.01 per share, for a total transaction of $500,625.00. Following the acquisition, the director now owns 306,887 shares in the company, valued at $2,458,164.87. This represents a 25.57% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Todd A. Becker sold 134,250 shares of the stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $10.75, for a total value of $1,443,187.50. Following the sale, the director now owns 195,687 shares in the company, valued at approximately $2,103,635.25. This trade represents a 40.69% decrease in their position. The disclosure for this sale can be found here. 1.40% of the stock is owned by insiders.

Institutional Investors Weigh In On Core Scientific

A number of large investors have recently bought and sold shares of CORZ. FMR LLC boosted its holdings in shares of Core Scientific by 2,937.7% during the fourth quarter. FMR LLC now owns 7,436,229 shares of the company’s stock worth $104,479,000 after purchasing an additional 7,191,428 shares during the last quarter. Vanguard Group Inc. boosted its holdings in shares of Core Scientific by 54.3% during the fourth quarter. Vanguard Group Inc. now owns 19,378,652 shares of the company’s stock worth $272,270,000 after purchasing an additional 6,819,406 shares during the last quarter. Helix Partners Management LP acquired a new stake in shares of Core Scientific during the fourth quarter worth $86,498,000. Driehaus Capital Management LLC boosted its holdings in shares of Core Scientific by 112.1% during the fourth quarter. Driehaus Capital Management LLC now owns 10,264,204 shares of the company’s stock worth $144,212,000 after purchasing an additional 5,424,901 shares during the last quarter. Finally, Fred Alger Management LLC acquired a new stake in shares of Core Scientific during the fourth quarter worth $62,011,000.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.